Analyst Ratings for Quest Diagnostics (DGX)
DGX Rating Summary
DGX Price Target Summary
- Highest: $245.00 (BofA Securities)
- Lowest: $200.00 (Piper Sandler)
- Average: $225.15
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$225.15 (+6.9%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
Avg. $ Target:
$225.15 (+6.9%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/2/2026 | Barclays » Updated 4/21/2026 |
Luke Sergott | Upgrade | Overweight (Equalweight) |
230.00 (225.00) |
182.35 (210.68) |
15.54% | Details |
| 8/25/2025 | Baird » Updated 7/13/2026 |
Eric Coldwell | Downgrade | Neutral (Outperform) |
236.00 (232.00) |
183.72 (210.68) |
14.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
